Intel (NASDAQ:INTC) Shares Up 2.3% After Analyst Upgrade

Intel Corporation (NASDAQ:INTC) shot up 2.3% during mid-day trading on Monday after Mizuho raised their price target on the stock from $23.00 to $39.00. Mizuho currently has a neutral rating on the stock. Intel traded as high as $37.51 and last traded at $37.22. 100,589,159 shares changed hands during mid-day trading, a decline of 3% from the average session volume of 103,517,438 shares. The stock had previously closed at $36.37.

INTC has been the topic of a number of other research reports. Seaport Res Ptn upgraded shares of Intel from a “strong sell” rating to a “hold” rating in a research report on Wednesday, September 24th. New Street Research increased their price objective on shares of Intel from $23.00 to $32.00 in a research report on Friday, September 19th. Wall Street Zen upgraded shares of Intel from a “sell” rating to a “hold” rating in a research report on Saturday, September 13th. Bank of America restated an “underperform” rating and set a $34.00 price objective on shares of Intel in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Intel from $23.00 to $30.00 and gave the company a “hold” rating in a research report on Monday, September 29th. Two research analysts have rated the stock with a Buy rating, twenty-two have issued a Hold rating and eight have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $27.60.

Institutional Trading of Intel

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. N.E.W. Advisory Services LLC purchased a new stake in shares of Intel in the first quarter worth $25,000. HFM Investment Advisors LLC purchased a new stake in shares of Intel in the first quarter worth $25,000. MJT & Associates Financial Advisory Group Inc. purchased a new stake in shares of Intel in the first quarter worth $27,000. West Branch Capital LLC purchased a new stake in shares of Intel in the second quarter worth $28,000. Finally, Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna purchased a new stake in shares of Intel in the second quarter worth $28,000. 64.53% of the stock is owned by hedge funds and other institutional investors.

Intel Trading Up 2.3%

The stock’s 50 day moving average price is $27.52 and its 200-day moving average price is $23.34. The company has a quick ratio of 0.92, a current ratio of 1.24 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $162.91 billion, a PE ratio of -7.80 and a beta of 1.33.

Intel (NASDAQ:INTC) last announced its quarterly earnings data on Thursday, July 24th. The chip maker reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.11). The firm had revenue of $12.86 billion during the quarter, compared to analysts’ expectations of $11.88 billion. Intel had a negative return on equity of 3.78% and a negative net margin of 38.64%.The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the company earned $0.02 earnings per share. Intel has set its Q3 2025 guidance at 0.000-0.000 EPS. On average, sell-side analysts expect that Intel Corporation will post -0.11 earnings per share for the current fiscal year.

About Intel

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.